AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 156 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $645,000 | +4.0% | 19,314 | 0.0% | 0.03% | 0.0% |
| Q2 2014 | $620,000 | -30.5% | 19,314 | 0.0% | 0.03% | -32.6% |
| Q1 2014 | $892,000 | -24.9% | 19,314 | +15.5% | 0.05% | -24.6% |
| Q4 2013 | $1,187,000 | -17.2% | 16,724 | 0.0% | 0.06% | -21.8% |
| Q3 2013 | $1,434,000 | -12.2% | 16,724 | -35.2% | 0.08% | -15.2% |
| Q2 2013 | $1,634,000 | – | 25,804 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,637,455 | $42,852,000 | 9.04% |
| Broadfin Capital, LLC | 2,502,578 | $65,492,000 | 5.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $140,005,000 | 3.03% |
| HighVista Strategies LLC | 265,110 | $6,938,000 | 1.11% |
| Perceptive Advisors | 381,100 | $9,973,000 | 0.78% |
| Healthcare Value Capital, LLC | 25,000 | $654,000 | 0.71% |
| ADVENT INTERNATIONAL, L.P. | 347,001 | $9,081,000 | 0.70% |
| Birchview Capital, LP | 46,000 | $1,204,000 | 0.63% |
| NORTH TIDE CAPITAL, LLC | 300,000 | $7,851,000 | 0.59% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,323,633 | $60,809,000 | 0.35% |